Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Ming-Tsung Lin"'
Autor:
Ming-Chao Tsai, Chih-Chi Wang, Wei-Chen Lee, Chih-Che Lin, Kuo-Chin Chang, Chien-Hung Chen, Chao-Hung Hung, Ming-Tsung Lin, Chang-Chun Hsiao, Chao-Long Chen, Rong-Nan Chien, Tsung-Hui Hu
Publikováno v:
Liver Cancer, Pp 1-16 (2021)
Background: It is unclear whether entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have different effects on hepatocellular carcinoma (HCC) recurrence and death in patients receiving curative hepatectomy for hepatitis B virus (HBV)-related HCC
Externí odkaz:
https://doaj.org/article/7136cae453d54b1e8f5bdfc9cd09fec0
Autor:
Ming-Tsung Lin, Kuo-Chin Chang, Yi-Hao Yen, Ming-Chao Tsai, Chien-Hung Chen, Jing-Houng Wang, Chang-Chun Hsiao, Yueh-Hsia Chiu, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 1, Pp 621-628 (2021)
Background/Purpose: Effective antiviral-therapy can reduce the risk of liver cirrhosis related hepatocellular carcinoma in patients with chronic hepatitis B and hepatitis C. Yet, the difference of hepatocellular carcinoma development in chronic hepat
Externí odkaz:
https://doaj.org/article/8663454c9c564cd7a1742faeaa2665f0
Autor:
Ming-Chao Tsai, Yi-Hao Yen, Kuo-Chin Chang, Chao-Hung Hung, Chien-Hung Chen, Ming-Tsung Lin, Tsung-Hui Hu
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Urokinase plasminogen activator (uPA) is an extracellular matrix-degrading protease that is involved in the invasiveness and progression of cancer. There is good evidence that uPA expression is a clinically relevant biomarker in s
Externí odkaz:
https://doaj.org/article/55f7402fe24542b8a6e2d2dce06e8de6
Autor:
Kuo-Chin Chang, Ming-Tsung Lin, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Sherry Yueh-Hsia Chiu, Tsung-Hui Hu
Publikováno v:
Viruses, Vol 14, Iss 12, p 2671 (2022)
Hepatitis B core-related antigen (HBcrAg) is a predictor of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients. Studies on anti-viral therapy have shown that the use of NUC therapy in HBV patients could reduce the incidence of HCC.
Externí odkaz:
https://doaj.org/article/d95ccd825c994efcb0ac7336844d1046
Autor:
Fai-Meng Sou, Cheng-Kun Wu, Kuo-Chin Chang, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Kwong-Ming Kee, Yi-Hao Yen, Ming-Tsung Lin, Ming-Chao Tsai, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 1, Pp 504-513 (2019)
Background: Hepatitis C virus (HCV)-infected patients who achieved sustained virologic response (SVR) may still develop hepatocellular carcinoma (HCC). The characteristic of HCC and the prognosis between SVR and non-SVR patients were not well known.
Externí odkaz:
https://doaj.org/article/96d7fbf0375340c3853a8e33004d3bd4
Autor:
Wei-Ru Cho, Chih-Chi Wang, Meng-Yun Tsai, Chen-Kai Chou, Yueh-Wei Liu, Yi-Ju Wu, Ming-Tsung Lin, Kuang-Den Chen, Ching-Hui Chuang, Pao-Yuan Huang, Tsung-Hui Hu, Ming-Chao Tsai
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0247231 (2021)
BackgroundMetformin is proposed to have chemopreventive effect of various cancer currently. However, the anti-cancer effect of metformin for diabetic patients with hepatocellular carcinoma (HCC) undergoing liver resection remains unclear. The aim of
Externí odkaz:
https://doaj.org/article/2e0e24afe7e8402da8a89c88835664da
Autor:
Kuo-Chin Chang, Yi-Hao Ye, Cheng-Kun Wu, Ming-Tsung Lin, Ming-Chao Tsai, Po-Lin Tseng, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 11, Pp 1011-1018 (2018)
Background/Purpose: Although antiviral therapy reduces development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC), HCC often develops in patients with non-sustained virologic response (non-SVR). We aimed to evaluate risk
Externí odkaz:
https://doaj.org/article/b0f77cd19bcb43b1bf4ea70c75ce6a42
Autor:
Yi-Hao Yen, Ming-Chao Tsai, Cheng-Kun Wu, Kuo-Chin Chang, Chao-Hung Hung, King-Wah Chiu, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Kwong-Ming Kee, Yuan-Hung Kuo, Po-Lin Tseng, Ming-Tsung Lin, Chao-Min Huang, Jung-Ting Lin, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 9, Pp 833-840 (2018)
Background/Purpose: Prdevious meta-analyses assess whether or not patatin-like phospholipase domain containing 3 (PNPLA3) (rs738409 C > G) was associated with increased risk of hepatocellular carcinoma (HCC) in Caucasians patients with hepatitis C vi
Externí odkaz:
https://doaj.org/article/f91f66c4eb634580b34681c6817aa48b
Autor:
Yi-Hao Yen, Kuo-Chin Chang, Ming-Chao Tsai, Po-Lin Tseng, Ming-Tsung Lin, Cheng-Kun Wu, Jung-Ting Lin, Tsung-Hui Hu, Jing-Houng Wang, Chien-Hung Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 4, Pp 268-275 (2018)
Background/Purpose: Metabolic risk factors are associated with liver fibrosis. Whether or not metabolic risk factors affect the severity of liver fibrosis in patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), or risk factors associat
Externí odkaz:
https://doaj.org/article/6970751adaef4fb7a22c8b8441067ed2
Autor:
Yi-Hao Yen, Jung-Fu Chen, Cheng-Kun Wu, Ming-Tsung Lin, Kuo-Chin Chang, Po-Lin Tseng, Ming-Chao Tsai, Jung-Ting Lin, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 116, Iss 11, Pp 852-861 (2017)
Controlled attenuation parameter (CAP) is a method for measuring steatosis based on FibroScan. Despite observer dependency, ultrasound (US) robustly diagnoses moderate and severe steatosis. Here, we aimed to evaluate the correlation of CAP with US-id
Externí odkaz:
https://doaj.org/article/4858e34ead254b24937ba57f4d8ac1e6